Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

PURPOSE: To update eligibility and outcome measures in trials that evaluate systemic treatment for patients with progressive prostate cancer and castrate levels of testosterone. METHODS: A committee of investigators experienced in conducting trials for prostate cancer defined new consensus criteria...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Scher, Howard I., Halabi, Susan, Tannock, Ian, Morris, Michael, Sternberg, Cora N., Carducci, Michael A., Eisenberger, Mario A., Higano, Celestia, Bubley, Glenn J., Dreicer, Robert, Petrylak, Daniel, Kantoff, Philip, Basch, Ethan, Kelly, William Kevin, Figg, William D., Small, Eric J., Beer, Tomasz M., Wilding, George, Martin, Alison, Hussain, Maha
التنسيق: Artigo
اللغة:Inglês
منشور في: 2008
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010133/
https://ncbi.nlm.nih.gov/pubmed/18309951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.12.4487
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة